These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21715058)

  • 21. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menace in the mix. Avoiding drug interactions with food, herbs and nutrients.
    Bancroft B
    Adv Nurse Pract; 2007 Dec; 15(12):33-7; quiz 38. PubMed ID: 20014671
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
    Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC
    Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute dyspnea and maculo-papular eruption after taking acenocoumarol (Sintrom].
    Kamm W; Berger JP
    Rev Med Suisse Romande; 1998 Jun; 118(6):565-8. PubMed ID: 9689868
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary localised conjunctival amyloidosis presenting as subconjunctival haemorrhage.
    Cheong-Leen R
    Eye (Lond); 2001 Oct; 15(Pt 5):679-80. PubMed ID: 11702995
    [No Abstract]   [Full Text] [Related]  

  • 26. Idiopathic recurrent subconjunctival hemorrhage.
    Wu AY; Kugathasan K; Harvey JT
    Can J Ophthalmol; 2012 Oct; 47(5):e28-9. PubMed ID: 23036560
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conjunctival hemorrhage. Acute manifestation benign, long-term alarming].
    Holzgreve H
    MMW Fortschr Med; 2013 Oct; 155(18):33. PubMed ID: 24288915
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monitoring antivitamin K treatment: a notebook for the patient].
    Buxeraud J
    Rev Infirm; 2004 Apr; (100):38-41. PubMed ID: 15222184
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ulcer in the oral mucosa of torpid course and conjunctival injection].
    Pintor Holguín E; Llamas Cascón E; Pedrajas Navas JM; Téllez Molina MJ; Audibert Mena L
    Rev Clin Esp; 1998 Jun; 198(6):399-400. PubMed ID: 9691751
    [No Abstract]   [Full Text] [Related]  

  • 30. Subconjunctival haemorrhage as an indication of gastrointestinal bleeding.
    Chatziralli IP; Jaulim A; Chatzirallis A; Moschos MM
    Clin Exp Optom; 2016 Jan; 99(1):93. PubMed ID: 26346714
    [No Abstract]   [Full Text] [Related]  

  • 31. A conjunctival cyst with delayed internal hemorrhage after strabismus surgery.
    Kim JH; Oh SY
    J AAPOS; 2008 Aug; 12(4):409-11. PubMed ID: 18708010
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-traumatic subconjunctival haemorrhages.
    Canning CR
    Practitioner; 1987 Feb; 231(1424):140. PubMed ID: 3684900
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute Epstein-Barr virus infection causing bilateral conjunctival hemorrhages.
    Kanafani ZA; Bashur Z; Kanj SS
    South Med J; 2005 Mar; 98(3):390-1. PubMed ID: 15813169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Goji berries and anticoagulants: bleeding.
    Prescrire Int; 2013 Oct; 22(142):244. PubMed ID: 24298594
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
    ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
    Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An endogenous foreign body found after subconjunctival hemorrhage.
    Sze E; Finefrock D; Rosenberg N; Rosenberg M
    Am J Emerg Med; 2017 Feb; 35(2):376.e3-376.e4. PubMed ID: 27666755
    [No Abstract]   [Full Text] [Related]  

  • 37. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
    Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picture of the month: Coughing paroxysms associated with subconjunctival hemorrhage and dellen.
    Reisli I; Keles S; Kamis U; Elmas S; Ozturk BT
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):53-5. PubMed ID: 16389211
    [No Abstract]   [Full Text] [Related]  

  • 40. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.